日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL

在弥漫性大B细胞淋巴瘤(DLBCL)中,抗体诱导的补体激活后,细胞骨架动力学和线粒体重排驱动细胞命运。

van der Horst, Hilma J; Csikós, Tamás; Quik, Marjolein; van der Schans, Jort J; de Lint, Klaas; Nuñez Moreno, Gonzalo; Guan, Meijian; Karagoz, Kubra; Breij, Esther C W; Santegoets, Kim C M; Chamuleau, Martine E D; Roukens, M Guy; Overdijk, Marije B; Mutis, Tuna

A hexamerization-enhanced, Fc-silenced agonistic CD27 antibody amplifies T-cell effector functions as single agent and in combination with PD-1 blockade

一种经六聚化增强、Fc沉默的激动性CD27抗体,可作为单药或与PD-1阻断剂联合使用,增强T细胞效应功能。

Işıl Altıntaş,Kristina B Nürmberger,Andrea Imle,Anna-Lena Krause,Marike M van Beuge,Aras Toker,Andreea Ioan-Facsinay,Jordan Blum,Alexander Muik,Frank J Beurskens,Rob N de Jong,David P E Satijn,Friederike Gieseke,Bart-Jan de Kreuk,Maarten van der Kroef,Sina Fellermeier-Kopf,Tahamtan Ahmadi,Özlem Türeci,Esther C W Breij,Uğur Şahin

A hexamerization-enhanced, Fc-silenced agonistic CD27 antibody amplifies T-cell effector functions as single agent and in combination with PD-1 blockade

一种经六聚化增强、Fc沉默的激动性CD27抗体,可作为单药或与PD-1阻断剂联合使用,增强T细胞效应功能。

Işıl Altıntaş ,Kristina B Nürmberger ,Andrea Imle ,Anna-Lena Krause ,Marike M van Beuge ,Aras Toker ,Andreea Ioan-Facsinay ,Jordan Blum ,Alexander Muik ,Frank J Beurskens ,Rob N de Jong ,David P E Satijn ,Friederike Gieseke ,Bart-Jan de Kreuk ,Maarten van der Kroef ,Sina Fellermeier-Kopf ,Tahamtan Ahmadi ,Özlem Türeci ,Esther C W Breij ,Uğur Şahin

Feasibility and potential effectiveness of nurse-led video-coaching interventions for childhood, adolescent, and young adult cancer survivors: the REVIVER study

护士主导的视频辅导干预对儿童、青少年和青年癌症幸存者的可行性和潜在有效性:REVIVER 研究

Bouwman, Eline; Stollman, Iridi; Wilbers, Joyce; Claessens, Joyce J M; van Spronsen, Dick Johan; Bongaerts, Annet; Breij, Dionne; Blijlevens, Nicole M A; Knoop, Hans; Hermens, Rosella P M G; Loonen, Jacqueline J

Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity

HexaBody-CD38 是一种具有优异补体依赖性细胞毒活性的新一代 CD38 抗体,其临床前抗肿瘤活性研究显示其具有良好的抗肿瘤活性。

Ida H Hiemstra,Kim C M Santegoets,Maarten L Janmaat,Bart E C G De Goeij,Wessel Ten Hagen,Sanne van Dooremalen,Peter Boross,Jeroen van den Brakel,Sieto Bosgra,Grietje Andringa,Berris van Kessel-Welmers,Dennis Verzijl,Richard G Hibbert,Kristine A Frerichs,Tuna Mutis,Niels W C J van de Donk,Tahamtan Ahmadi,David Satijn,A Kate Sasser,Esther C W Breij

Antibodies as drugs-a Keystone Symposia report

抗体作为药物——基石研讨会报告

Cable, Jennifer; Saphire, Erica Ollmann; Hayday, Adrian C; Wiltshire, Timothy D; Mousa, Jarrod J; Humphreys, David P; Breij, Esther C W; Bruhns, Pierre; Broketa, Matteo; Furuya, Genta; Hauser, Blake M; Mahévas, Matthieu; Carfi, Andrea; Cantaert, Tineke; Kwong, Peter D; Tripathi, Prabhanshu; Davis, Jonathan H; Brewis, Neil; Keyt, Bruce A; Fennemann, Felix L; Dussupt, Vincent; Sivasubramanian, Arvind; Kim, Philip M; Rawi, Reda; Richardson, Eve; Leventhal, Daniel; Wolters, Rachael M; Geuijen, Cecile A W; Sleeman, Matthew A; Pengo, Niccolo; Donnellan, Francesca Rose

Systematic study of tissue factor expression in solid tumors

实体肿瘤中组织因子表达的系统研究

Johann S de Bono, Jeffrey R Harris, Saskia M Burm, Adriaan Vanderstichele, Mischa A Houtkamp, Saida Aarass, Ruth Riisnaes, Ines Figueiredo, Daniel Nava Rodrigues, Rossitza Christova, Siel Olbrecht, Hans W M Niessen, Sigrid R Ruuls, Danita H Schuurhuis, Jeroen J Lammerts van Bueren, Esther C W Breij,

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

针对晚期难治性实体瘤患者的靶向PD-L1和4-1BB的双特异性抗体(GEN1046)的临床前特征和I期试验结果

Alexander Muik,Elena Garralda,Isil Altintas,Friederike Gieseke,Ravit Geva,Eytan Ben-Ami,Corinne Maurice-Dror,Emiliano Calvo,Patricia M LoRusso,Guzman Alonso,Maria E Rodriguez-Ruiz,Kristina B Schoedel,Jordan M Blum,Bianca Sänger,Theodora W Salcedo,Saskia M Burm,Eliana Stanganello,Dennis Verzijl,Fulvia Vascotto,Angelica Sette,Juliane Quinkhardt,Theo S Plantinga,Aras Toker,Edward N van den Brink,Mark Fereshteh,Mustafa Diken,David Satijn,Sebastian Kreiter,Esther C W Breij,Gaurav Bajaj,Eleni Lagkadinou,Kate Sasser,Özlem Türeci,Ulf Forssmann,Tahamtan Ahmadi,Uğur Şahin #,Maria Jure-Kunkel #,Ignacio Melero #

DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

DuoBody-CD40x4-1BB 通过条件性 CD40 和 4-1BB 激动剂活性诱导树突状细胞成熟并增强 T 细胞活化。

Alexander Muik ,Homer C Adams 3rd ,Friederike Gieseke ,Isil Altintas ,Kristina B Schoedel ,Jordan M Blum ,Bianca Sänger ,Saskia M Burm ,Eliana Stanganello ,Dennis Verzijl ,Vanessa M Spires ,Fulvia Vascotto ,Aras Toker ,Juliane Quinkhardt ,Mark Fereshteh ,Mustafa Diken ,David P E Satijn ,Sebastian Kreiter ,Tahamtan Ahmadi ,Esther C W Breij ,Özlem Türeci ,Kate Sasser ,Ugur Sahin ,Maria Jure-Kunkel

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models

DuoBody-CD3x5T4 在临床前肿瘤模型中的机制和药效学研究

Kristel Kemper ,Ellis Gielen ,Peter Boross ,Mischa Houtkamp ,Theo S Plantinga ,Stefanie Ah de Poot ,Saskia M Burm ,Maarten L Janmaat ,Louise A Koopman ,Edward N van den Brink ,Rik Rademaker ,Dennis Verzijl ,Patrick J Engelberts ,David Satijn ,A Kate Sasser ,Esther Cw Breij